Size | Price | Stock | Qty |
---|---|---|---|
1mg |
|
||
5mg |
|
||
10mg |
|
||
Other Sizes |
|
ln Vitro |
In a dose-dependent manner, MTX-23 (compound 16; 0-20 μM; 4 d; 22Rvl cells) suppresses cell proliferation [1]. AR-V7 protein levels are decreased by MTX-23 (10 μM; 4 d; 22Rvl cells) [1]. MTX-23 (1 μM; 0-48 h; 22Rvl cells) raises the level of annexin-V staining and causes apoptosis [1].
|
---|---|
ln Vivo |
In nu/nu mice carrying 22Rvl-EnzR tumor xenografts, MTX-23 (compound 16; 2.5 mg/mL; intratumoral injection) suppresses tumor growth [1].
|
Cell Assay |
Cell Viability Assay[1]
Cell Types: 22Rvl cells Tested Concentrations: 0-20 μM Incubation Duration: 4 days Experimental Results: decreased the cell count by less than 50 percent. Apoptosis Analysis[1] Cell Types: 22Rvl cells Tested Concentrations: 1 μM Incubation Duration: 0-48 h Experimental Results: Induced cell apoptosis in 22Rvl cells. Western Blot Analysis[1] Cell Types: 22Rvl cells Tested Concentrations: 10 μM Incubation Duration: 4 days Experimental Results: decreased AR-V7 protein levels. |
Animal Protocol |
Animal/Disease Models: nu/nu (nude) mice with 22Rvl-EnzR tumor xenografts[1]
Doses: 2.5 mg/mL Route of Administration: intratumor injection Experimental Results: Inhibited tumor growth in nu /nu (nude) mice with 22Rvl-EnzR tumor xenografts. |
References |
[1]. Jenny D, et, al. Bi-functional compounds and methods for targeted ubiquitination of androgen receptor. WO2021236695.
|
Molecular Formula |
C43H53F2N7O7S2
|
---|---|
Molecular Weight |
882.05
|
CAS # |
2488296-74-6
|
Appearance |
Typically exists as solids (or liquids in special cases) at room temperature
|
SMILES |
S1C=NC(C)=C1C1C=CC(=CC=1)[C@H](C)NC([C@@H]1C[C@H](CN1C([C@H](C(C)(C)C)NC(CCCCNC(COC1=C(C(=CC=C1C1=CSC(=N1)N1CCOCC1)F)F)=O)=O)=O)O)=O
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : 100 mg/mL (113.37 mM)
|
---|---|
Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.1337 mL | 5.6686 mL | 11.3372 mL | |
5 mM | 0.2267 mL | 1.1337 mL | 2.2674 mL | |
10 mM | 0.1134 mL | 0.5669 mL | 1.1337 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.